Warrior CARE: Cannabis Behavioral Health
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age19-69
SponsorWayne State University
About this trial
This study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.
Eligibility criteria
Qualifiers
a healthy veteran who has served in a branch of the US armed forces
report using cannabis within the past year
currently meet DSM-5 criteria for PTSD and a score of 25 or greater on the CAPS-5 (the anchor, or index, trauma does not have to be related to military service)
between the ages of 19-69 years old
Disqualifiers
pregnant, lactating, or heterosexually active women and not using medically approved birth control
current or past bipolar or psychotic disorder as determined using the SCID-5
at immediate high risk for suicide based on the C-SSRS
current SUD other than Nicotine Use Disorder and Alcohol Use Disorder (mild or moderate)
Trial design
Treatments tested in this trial
- Tetrahydrocannabinol
- Cannabidiol
- Placebo
Treatment groups
500 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov